PER 2.47% 7.9¢ percheron therapeutics limited

bioshares - strong buy, page-12

  1. 22 Posts.
    re: bioshares - buy? If its proof of antisense technology that you require, chew on this fact.

    "Vitravene (fomivirsen) is the first antisense drug to achieve marketing clearance. Vitravene treats a condition called cytomegalovirus (CMV) retinitis in people with AIDS. Isis developed the drug and licensed the worldwide commercial rights to Novartis Ophthalmics (formerly CibaVision.)"

    sources :

    http://www.isispharm.com/vitravene.html
    http://www.isispharm.com/product_pipeline.html

    Was hoping for your learned dissection of the Enbrel product, dv phan. Nervemind my interest in ANP and
    antisense tech has reached its end.

    Ciao
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.9¢
Change
-0.002(2.47%)
Mkt cap ! $81.90M
Open High Low Value Volume
8.0¢ 8.0¢ 7.9¢ $230.1K 2.904M

Buyers (Bids)

No. Vol. Price($)
1 51000 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 163520 2
View Market Depth
Last trade - 15.57pm 01/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.